P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

Detalles Bibliográficos
Autores principales: Shen, Haorui, Wu, Jia-Zhu, Liang, Jinhua, Yin, Hua, Wang, LI, LI, Jianyong, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431123/
http://dx.doi.org/10.1097/01.HS9.0000971476.26929.92
_version_ 1785091125377236992
author Shen, Haorui
Wu, Jia-Zhu
Liang, Jinhua
Yin, Hua
Wang, LI
LI, Jianyong
Xu, Wei
author_facet Shen, Haorui
Wu, Jia-Zhu
Liang, Jinhua
Yin, Hua
Wang, LI
LI, Jianyong
Xu, Wei
author_sort Shen, Haorui
collection PubMed
description
format Online
Article
Text
id pubmed-10431123
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311232023-08-17 P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) Shen, Haorui Wu, Jia-Zhu Liang, Jinhua Yin, Hua Wang, LI LI, Jianyong Xu, Wei Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431123/ http://dx.doi.org/10.1097/01.HS9.0000971476.26929.92 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Shen, Haorui
Wu, Jia-Zhu
Liang, Jinhua
Yin, Hua
Wang, LI
LI, Jianyong
Xu, Wei
P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
title P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
title_full P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
title_fullStr P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
title_full_unstemmed P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
title_short P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
title_sort p1145: preliminary results of penpulimab combined with rma(rituximab, methotrexate, and cytarabine) for newly diagnosed primary central nervous system lymphoma (pcnsl)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431123/
http://dx.doi.org/10.1097/01.HS9.0000971476.26929.92
work_keys_str_mv AT shenhaorui p1145preliminaryresultsofpenpulimabcombinedwithrmarituximabmethotrexateandcytarabinefornewlydiagnosedprimarycentralnervoussystemlymphomapcnsl
AT wujiazhu p1145preliminaryresultsofpenpulimabcombinedwithrmarituximabmethotrexateandcytarabinefornewlydiagnosedprimarycentralnervoussystemlymphomapcnsl
AT liangjinhua p1145preliminaryresultsofpenpulimabcombinedwithrmarituximabmethotrexateandcytarabinefornewlydiagnosedprimarycentralnervoussystemlymphomapcnsl
AT yinhua p1145preliminaryresultsofpenpulimabcombinedwithrmarituximabmethotrexateandcytarabinefornewlydiagnosedprimarycentralnervoussystemlymphomapcnsl
AT wangli p1145preliminaryresultsofpenpulimabcombinedwithrmarituximabmethotrexateandcytarabinefornewlydiagnosedprimarycentralnervoussystemlymphomapcnsl
AT lijianyong p1145preliminaryresultsofpenpulimabcombinedwithrmarituximabmethotrexateandcytarabinefornewlydiagnosedprimarycentralnervoussystemlymphomapcnsl
AT xuwei p1145preliminaryresultsofpenpulimabcombinedwithrmarituximabmethotrexateandcytarabinefornewlydiagnosedprimarycentralnervoussystemlymphomapcnsl

Ejemplares similares